14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CCAP vs CION: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, CION Investment Corporation (CION) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CCAP carries a Unified Composite Score of 19.6/100 (STRONG SELL) at $10.08 (7.0x Forward P/E, 78.4% operating margin), whereas CION carries 41.8/100 (SELL) at $5.99 (5.4x Forward P/E, 76.3% operating margin).
Defensive Composite Rating Caution: Although CION compares more favorably head-to-head, both CCAP (19.6/100 STRONG SELL) and CION (41.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3); meanwhile CION is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCAP vs CION. Trailing 12-month operating profitability (CCAP 78.4% vs CION 76.3%) and valuation multiples (CCAP 7.0x vs CION 5.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Asset Management value chain with $372.1M market capitalization and 78.4% operating margin.
OpEx & R&D Reinvestment21.6% of Rev ($34M)
90D Engineering Disclosures0 Published
CION Moat ProfileHigh-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $296.4M market capitalization and 76.3% operating margin.
OpEx & R&D Reinvestment23.7% of Rev ($55M)
90D Engineering Disclosures0 Published
Investor FAQ CCAP vs CION Key Questions & Quantitative Answers
As of Nov 16, 2026, CION Investment Corporation (CION) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CCAP carries a Unified Composite Score of 19.6/100 (STRONG SELL) at $10.08 (7.0x Forward P/E, 78.4% operating margin), whereas CION carries 41.8/100 (SELL) at $5.99 (5.4x Forward P/E, 76.3% operating margin). Defensive Composite Rating Caution: Although CION compares more favorably head-to-head, both CCAP (19.6/100 STRONG SELL) and CION (41.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3); meanwhile CION is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CION leads the Growth & Scale pillar: CCAP posts -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin), compared with CION at -4.7% YoY revenue growth and +20.2% YoY earnings growth on $232M TTM revenue (100.0% gross margin, 76.3% operating margin). On trailing 12-month operating scale, CCAP generates $156M in USD-normalized revenue versus $232M for CION. In operating R&D and SG&A reinvestment, CCAP deploys 21.6% of Rev ($34M) (0 90-day corporate R&D disclosures) versus 23.7% of Rev ($55M) (0 disclosures) for CION.
CION screens cheaper on headline valuation multiples. CCAP trades at 7.0x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin), whereas CION trades at 5.4x Forward P/E, 6.8x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CCAP (-0.5% ROE) versus CION (0.4% ROE) capital efficiency.
In options market volatility and institutional positioning, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk). By comparison, CION carries 36.2% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.02β · 42% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.